Changeflow GovPing Healthcare & Life Sciences FDA Variance Approval Letter for Alexander Kulik
Routine Guidance Added Final

FDA Variance Approval Letter for Alexander Kulik

Favicon for www.regulations.gov Regs.gov: Food and Drug Administration
Published
Detected
Email

Summary

The FDA has issued a variance approval letter to Alexander Kulik, as posted on March 20, 2026. The letter, issued by the Center for Devices and Radiological Health (CDRH), pertains to a specific variance request.

Published by FDA on regulations.gov . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

The FDA's Center for Devices and Radiological Health (CDRH) has issued a variance approval letter to Alexander Kulik. The document, dated March 20, 2026, indicates that a specific variance request has been approved. Due to the restricted nature of the information, only a redacted version of the letter is publicly available.

This approval signifies that a specific deviation from standard FDA regulations has been granted for the named individual or entity. Compliance officers should note that while this is an individual approval, it may set a precedent or provide insight into the FDA's considerations for similar variance requests in the future, particularly concerning medical devices or pharmaceuticals.

Archived snapshot

Mar 21, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

Content

There are no documents available to view or download

Attachments 2

Variance Approval Letter to Alexander Kulik

Restricted: Personally Identifiable Information

More Information
- Author(s) CDRH

Variance Approval Letter to Alexander Kulik_Redacted

More Information
- Author(s) CDRH
Download

Get daily alerts for Regs.gov: Food and Drug Administration

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from FDA.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
FDA
Published
March 20th, 2026
Instrument
Guidance
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
FDA-2026-V-1592-0003
Docket
FDA-2026-V-1592

Who this affects

Applies to
Drug manufacturers Medical device makers Pharmaceutical companies
Industry sector
3254 Pharmaceutical Manufacturing 3345 Medical Device Manufacturing
Activity scope
Drug Labeling Medical Device Approval
Geographic scope
United States US

Taxonomy

Primary area
Healthcare
Operational domain
Compliance
Compliance frameworks
FDA 21 CFR Part 11 GxP
Topics
Medical Devices Pharmaceuticals

Get alerts for this source

We'll email you when Regs.gov: Food and Drug Administration publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!